investor.ligand.comLigand Pharmaceuticals Incorporated - Investor Relations

Overview News & Events Press Releases Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Form 8937 Analyst Coverage Financials Quarterly & Annual Results SEC Filings Governance Committee Composition Governance Documents Committee Charters Leadership Board of Directors Resources FAQs Email Alerts Investor Contacts Investor Relations Overview News & Events Press Releases Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Form 8937 Analyst Coverage Financials Quarterly & Annual Results SEC Filings Governance Committee Composition Governance Documents Committee Charters Leadership Board of Directors Resources FAQs Email Alerts Investor Contacts Corporate Overview Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value programs that can improve and extend lives around the world. Our diversified portfolio of royalty assets generates consistent and predictable revenue streams for our shareholders. It includes treatments for cancer, kidney disease, diabetes, nonalcoholic steatohepatitis, and other rare conditions that threaten lifespan and quality of life for billions of people. We also maintain and license our Captisol® technology platform with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. MoreLatest News View all news View All Quarters IR Contact [email protected] Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Ligand Pharmaceuticals Incorporated, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Ligand Pharmaceuticals Incorporated to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Events & Presentations Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Unsubscribe Email Alert Sign Up Confirmation Copyright © Ligand Pharmaceuticals Incorporated. All rights reserved. Privacy Policy Terms of...